Expert opinion from Gustavo Campos Doctor of Medicine · 9 years of experience · Brazil A patient with Alzheimer's disease in ...

Scientists have developed an artificially-intelligent tool that can accurately predict whether people with early signs of ...

LANS could only be diagnosed after death. Now, this relatively common form of dementia can be diagnosed during a patient's ...

Betty Pettit of Mooresville gained fame via her son Josh’s social-media accounts, which showcased the joys and pains of ...

In one of the longest acceptance speeches in modern American history, former President Donald Trump regaled delegates to the ...

With resignations of top leaders, Cassava Sciences exposes a dark, ugly corner of the Alzheimer’s disease world, ...

A novel Aβ-driven inhibitory mechanism on γ-secretases, which leads to substrate accumulation and reduced release of products, contributes to neurotoxicity by impairing γ-secretase signaling and might ...

Amyloid-beta (A-beta) aggregates are tangles of proteins most notably associated with neurodegenerative diseases such as ...

Over the years, there have been conflicting research findings on whether or not HMT may raise or lower a person’s risk of ...

The FDA approved donanemab, which will be sold under the brand name Kisunla. The new drug helps slow decline in Alzheimer's patients with mild cognitive impairment.

Outside of the budget, a new law sponsored by Rep. Bob Merski (D-2) will let more senior citizens access discounted vehicle ...